Coram Healthcare announces appointment of director.DENVER--(BUSINESS WIRE)--Nov. 7, 1994--Coram Healthcare Corp. (NYSE NYSE See: New York Stock Exchange :CRH CRH corticotropin-releasing hormone. CRH abbr. corticotropin-releasing hormone CRH corticotropin releasing hormone. ) Monday announced the appointment of Dr. Gail R. Wilensky to its board of directors. Dr. Wilensky presently is serving as a Senior Fellow at Project HOPE. Dr. Wilensky previously served in the Bush Administration as Deputy Assistant to the President for Policy Development, responsible for advising President Bush on health and welfare issues. Prior to her tenure at the White House, Dr. Wilensky served as the Administrator of the Health Care Financing Administration Health Care Financing Administration, n.pr department in the U.S. agency of Health and Human Services responsible for the oversight of the Medicaid and Medicare benefit programs, including guidelines, payment, and coverage policies. (HCFA HCFA abbr. Health Care Financing Administration HCFA, n.pr See Health Care Financing Administration. ) in the Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979 Health and Human Services, HHS , where she directed the Medicare and Medicaid Medicare and Medicaid U.S. government programs in effect since 1966. Medicare covers most people 65 or older and those with long-term disabilities. Part A, a hospital insurance plan, also pays for home health visits and hospice care. programs. From 1983 to 1990, Dr. Wilensky was vice president, Division of Health Affairs at Project HOPE. Dr. Wilensky is an elected member of the Institute of Medicine of the National Academy of Sciences. She also has served as a member of the Physician Payment Review Commission and the Health Advisory Committee of the General Accounting Office. Dr. Wilensky also serves on the board of directors of United Healthcare Corp., Marion Merrell Dow, Inc., Advanced Tissue Sciences, Inc., and Syncor International Corp. Coram also announced that Miles E. Gilman and Charles A. Laverty have resigned from Coram's board of directors. Mr. Gilman resigned in order to create room on the board for Dr. Wilensky. Mr. Laverty will devote more time and attention to his duties and responsibilities as president and chief executive officer of Davstar Industries, Inc. Patrick J. Fortune, Coram's president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , was appointed to the board seat vacated by Mr. Laverty. Coram Healthcare Corp. provides a wide range of alternate site healthcare delivery services including ambulatory and home infusion therapies, lithotripsy, and institutional pharmacy services. CONTACT: Coram Healthcare Paige Cosby, 303/672-8725 REPEATS: New York 212-575-8822 or 800-221-2462; Boston 617-330-5311 or |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion